# Genetic Mechanisms in Human Hypertension

> **NCT01456208** · — · TERMINATED · sponsor: **Brigham and Women's Hospital** · enrollment: 150 (actual)

## Conditions studied

- Hypertension

## Interventions

- **DRUG:** Para-aminohippuric Acid
- **DRUG:** Angiotensin II
- **DRUG:** Norepinephrine

## Key facts

- **NCT ID:** NCT01456208
- **Lead sponsor:** Brigham and Women's Hospital
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** TERMINATED
- **Start date:** 1999-10
- **Primary completion:** 2020-06
- **Final completion:** 2020-06
- **Target enrollment:** 150 (ACTUAL)
- **Why stopped:** Funding stopped
- **Last updated:** 2021-05-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01456208

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01456208, "Genetic Mechanisms in Human Hypertension". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01456208. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*